Retrospective Cohort Study
Copyright ©The Author(s) 2022.
World J Gastroenterol. May 21, 2022; 28(19): 2123-2136
Published online May 21, 2022. doi: 10.3748/wjg.v28.i19.2123
Table 2 Characteristics of non-acute respiratory distress syndrome and acute respiratory distress syndrome patients in derivation and validation cohorts
CharacteristicDerivation cohort
P valueValidation cohort
P value
non-ARDS (n = 345)
ARDS (n = 62)
non-ARDS (n = 153)
ARDS (n = 37)
Age (yr)49.0 (36.0; 64.0)42.0 (33.2; 59.5)0.06240.0 (33.0; 57.0)48.0 (41.0; 57.0)0.082
Female (%)138 (40.0) 20 (32.3) 0.31267 (43.8) 10 (27.0) 0.093
Weekend admission (%)73 (21.2) 18 (29.0) 0.22839 (25.5) 11 (29.7) 0.751
Etiology (%)0.0240.187
Biliary122 (35.4) 22 (35.5) 56 (36.6) 9 (24.3)
Hypertriglyceridemia119 (34.5) 30 (48.4) 53 (34.6) 12 (32.4)
Alcoholic28 (8.12) 6 (9.68) 8 (5.23) 5 (13.5)
Others76 (22.0) 4 (6.45) 36 (23.5) 11 (29.7)
Peritoneal irritation (%)80 (23.2) 25 (40.3) 0.00739 (25.5) 20 (54.1) 0.002
GCS < 15 (%)4 (1.16) 3 (4.84) 0.0754 (2.61) 6 (16.2) 0.004
Tem (℃)36.6 (36.4; 37.0)37.5 (36.5; 38.2)< 0.001 37.0 (36.8; 37.5)38.0 (37.8; 38.5)< 0.001
SBP (mmHg)129 (119; 140) 123 (110; 141) 0.113123 (116; 140) 119 (106; 147) 0.192
HR (bpm)82.0 (76.0; 96.0)120 (103; 134) < 0.001 90.0 (80.0; 110) 115 (100; 140) < 0.001
RR (bpm)20.0 (18.0; 20.0)23.0 (20.0; 30.0)< 0.001 20.0 (18.0; 22.0)24.0 (20.0; 29.0)< 0.001
WBC (× 109/L)11.9 (8.76; 15.3)13.9 (9.91; 19.5)0.00612.5 (9.07; 16.3)17.6 (13.6; 22.8)< 0.001
HCT (%)40.8 (37.5; 44.8)45.2 (38.3; 48.7)0.00241.3 (37.4; 45.2)43.9 (38.0; 49.4)0.094
PLT (× 109/L)218 (176; 275) 207 (167; 274) 0.26228 (192; 278) 208 (168; 261) 0.112
K (mmol/L)3.90 (3.60; 4.30)3.90 (3.50; 4.20)0.4413.90 (3.50; 4.20)3.90 (3.50; 4.40)0.429
Na (mmol/L)137 (134; 140) 137 (132; 140) 0.95137 (133; 140) 139 (132; 144) 0.038
Ca (mmol/L)2.25 (2.12; 2.34)1.88 (1.65; 2.12)< 0.001 2.16 (2.01; 2.29)1.96 (1.77; 2.22)0.002
Cr (μmol/L)67.0 (55.0; 81.0)86.5 (72.0; 134) < 0.001 62.0 (53.0; 79.0)96.0 (65.0; 230) < 0.001
BUN (mmol/L)5.03 (3.90; 6.44)7.28 (5.25; 10.3)< 0.001 4.80 (3.37; 6.48)6.97 (5.37; 14.4)< 0.001
Glu (mmol/L)8.10 (6.50; 13.1)11.0 (7.67; 16.1)< 0.001 8.80 (6.90; 13.6)11.3 (8.10; 16.8)0.032
Local complication (%)115 (33.3) 62 (100) < 0.00188 (57.5) 33 (89.2) 0.001
Ventilator (%)3 (0.87) 4 (6.45) 0.0120 (0.00) 23 (62.2) < 0.001
ICU admission (%)16 (4.64) 33 (53.2) < 0.00121 (13.7) 29 (78.4) < 0.001
ICU stays (d)0.00 (0.00; 0.00)2.50 (0.00; 11.8)< 0.001 0.00 (0.00; 0.00)7.00 (1.00; 11.0)< 0.001
Hospital stays (d)10.0 (7.00; 15.0)19.0 (11.0; 25.0)< 0.001 10.0 (4.00; 19.0)23.0 (15.0; 30.0)< 0.001
Mortality (%)1 (0.29) 2 (3.23) 0.0621 (0.65) 4 (10.8) 0.005